Fast Adoption Of Medtronic InSync ICD Fuels Strong Results In CRM
This article was originally published in The Gray Sheet
Executive Summary
Rapid uptake of Medtronic's InSync ICD resynchronization device has had a coattail effect on the firm's lower-voltage InSync bi-ventricular pacer
You may also be interested in...
St. Jude Relying On ICD Boom To Weather Slowdown In Pacer Sales
St. Jude continues to benefit from the rapidly expanding ICD market, although pacemaker sales are constrained by competition from cardiac resynchronization therapy (CRT) devices for congestive heart failure
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.